About Liferiver
Liferiver is a publicly listed company based in Shanghai (China) founded in 2005. Molecular diagnostic reagents and equipment are developed for pathogen detection. Its focus areas include Life Sciences, Life Sciences Platforms and Tools and Diversified.
Company details
Liferiver was established in 2005 in Shanghai, China, within the biotechnology sector. Molecular diagnostic reagents and equipment are developed and produced, with a focus on PCR-based detection kits for identifying pathogens in human and animal applications. Operations encompass the creation of specialized instruments and reagents tailored to diagnostic needs in healthcare and veterinary fields.
- Headquarters Shanghai, China
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website liferiver.com.cn
- Legal Name Shanghai Zj Bio-Tech Co. Ltd Class A
- Annual Revenue$17.7 M (USD)-30.3as on Dec 31, 2025
- Net Profit-$4.9 M (USD)73.09as on Dec 31, 2025
- EBITDA-$4.07 M (USD)85.52as on Dec 31, 2025
IPO & Listings of Liferiver
Liferiver is a publicly listed company on the SSE with ticker symbol 688317 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Jan 2021
- Listed onSSE: 688317
- Listed entityShanghai ZJ Bio-Tech Co. Ltd Class A
- Exchange sectorHealth technology
- ISINCNE100005DB6
- Share price17.43 CNY (-2.63% on the day) · 2026-10-14
- Market capitalisation3,398,202,506.00 CNY
- EPS (diluted, trailing year)-0.37 CNY
- Volume (last session)2,547,967
Financials of Liferiver
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 123.9M CNY | -34.3M CNY | -28.5M CNY |
| 2024 | 177.8M CNY | -127.5M CNY | -196.5M CNY |
| 2023 | 268.1M CNY | -136.9M CNY | -194.8M CNY |
| 2022 | 2.32B CNY | 760.3M CNY | 796.2M CNY |
| 2021 | 2.01B CNY | 758.5M CNY | 891.9M CNY |
Detailed financial statements for Liferiver
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Liferiver
Websites that share an audience with Liferiver (liferiver.com.cn).
Websites whose visitors overlap most with Liferiver. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
bt-dez.ru | bt-dez.ru | 100% | – | ||
clean-endoscope.ru | clean-endoscope.ru | 98% | – | ||
| artisbiotech.ro | 62% | View details | |||
| google.com | 40% | 85.8B | #1 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Liferiver
Complete news archive for Liferiver
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Liferiver
Liferiver was founded in 2005.
Liferiver is headquartered in Shanghai, China.
Annual revenue of Liferiver is $17.7M as on Dec 31, 2025.
Liferiver was established in 2005 in Shanghai, China, within the biotechnology sector. Molecular diagnostic reagents and equipment are developed and produced, with a focus on PCR-based detection kits for identifying pathogens in human and animal applications. Operations encompass the creation of specialized instruments and reagents tailored to diagnostic needs in healthcare and veterinary fields.
Yes, Liferiver is publicly traded on SSE under the ticker symbol 688317.